Psychometric study of the European Portuguese version of the PedsQL 3.0 Cancer Module. Health and Quality of Life Outcomes

• Autor(a) principal: Santos, Susana
• Data de Publicação: 2016
• Outros Autores: Batalha, Luís Manuel da Cunha, Crespo, Carla, Canavarro, Cristina, Fernandes, Ananda Maria, Campos, Diana Catarina Ferreira de, Pinto, Armando
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://web.esenfc.pt/?url=n3iZJD9O
• topic: European Portuguese version; PedsQL? 3.0 Cancer Module; Health-related quality of life; Pediatric cancer; Psychometric properties

Background Health-related quality of life (HRQoL) is an important outcome to assess the impact of cancer. This article examines the psychometric properties of the European Portuguese self-report version of the Pediatric Quality of Life Inventory™ Cancer Module (PedsQL™ 3.0 Cancer Module) in children and adolescents with cancer. Methods The participants, 332 children/adolescents diagnosed with cancer (8-18 years old), completed measures to assess HRQoL (PedsQL™ 3.0 Cancer Module and DISABKIDS Chronic Generic Measure; DCGM-12) and anxiety (Revised Children's Manifest Anxiety Scale - second edition; RCMAS-2). A subsample (n = 52) completed the PedsQL™ 3.0 Cancer Module a second time following one-week. The pediatric oncologists completed the Intensity of Treatment Rating Scale 3.0 (ITR 3.0). Results For the whole sample, the PedsQL™ 3.0 Cancer Module demonstrated good item discrimination (rs = .30 to .54). The confirmatory factor analysis testing the presence of eight first-order factors loading significantly in a second-order factor revealed an acceptable fit (CFI = .91; RMSEA = .05). The correlation of PedsQL™ 3.0 Cancer Module with DCGM-12 (rs = .17 to .58), and with RCMAS-2 (rs = −.16 to-.51) attested convergent validity. This inventory demonstrated minimally acceptable to very good internal consistency (?s = .65 to .87) and temporal stability (ICCs = .61 to .81). Conclusions These findings demonstrate that the European Portuguese self-report version of the PedsQL™ 3.0 Cancer Module is a valid and reliable instrument for assessing HRQoL in pediatric cancer.